一次細胞の世界市場レポート 2024年

一次細胞市場規模は、今後数年で急成長が見込まれます。2028年には22億4,000万米ドルに成長し、CAGRは10.6％となります。

予測期間には、個別化医療への需要の高まり、幹細胞研究への注目の高まり、この分野への投資の増加、セルベースアッセイの採用拡大など、いくつかの要因による成長が見込まれます。この期間に予想される主な動向には、ヒト一次細胞に対する需要の増加、研究ツールや技術の進歩、細胞ベースの治療法の採用拡大などがあります。これらの動向を総合すると、今後数年間における一次細胞関連の研究および応用の拡大・開発の有望な見通しが示されます。

がん研究に対する政府助成金の増加が予想され、近い将来の一次細胞市場の成長を牽引するものと思われます。政府資金は、プロジェクト資金、人材支援、インフラ開発、トレーニング、規制遵守、技術進歩など、1次細胞研究のさまざまな側面をサポートする上で重要な役割を果たしています。例えば、2022年5月、米国の米国がん研究所（AICR）は、2023年の資金として490億米ドルを求め、前年の配分額である464億米ドルから41億米ドルの増加を記録しました。このような資金提供の急増は、がん研究の進展における政府支援の重要な役割を強調するものであり、結果的に一次細胞市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の一次細胞市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場抑制要因
• 世界の一次細胞市場の実績：規模と成長、2018年～2023年
• 世界の一次細胞市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の一次細胞市場：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 造血細胞
• 皮膚細胞
• 消化管細胞
• 肝細胞
• 肺細胞
• 腎細胞
• 心臓細胞
• 筋骨格細胞
• その他一次細胞
• 世界の一次細胞市場：起源別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 人間の一次細胞
• 動物の一次細胞
• 世界の一次細胞市場：エンドユーザー別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 医薬品
• バイオテクノロジー企業
• 契約研究機関（CRO）
• 学術研究機関
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界の一次細胞市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界の一次細胞市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 一次細胞市場：競合情勢
• 一次細胞市場：企業プロファイル
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • BD Biosciences
  • Corning Incorporated
  • Cytiva

第31章 その他の大手企業と革新的企業

• Lonza Group Ltd
• Charles River Laboratories Inc.
• STEMCELL Technologies Inc
• American Type Culture Collection
• Cell Signaling Technology
• BioIVT
• InvivoGen
• HemaCare Corporation
• Creative Bioarray Inc.
• PromoCell GmbH
• CellGenix
• AllCells LLC
• Axol Bioscience Ltd
• PBS Biotech Inc
• AnaBios Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Primary cells are cells sourced directly from living tissues of animals or humans, subsequently processed to render them suitable for utilization in various cell treatments. These cells find application across a range of uses, such as 3D cell cultivation, virology, cancer research, stem cell treatment, and tissue restoration.

Primary cells encompass various types, including hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, among others. Hematopoietic cells, for instance, are a form of stem cell responsible for generating diverse blood cell types within the body. These cells originate from both human and animal primary sources and are utilized by pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and other entities for various applications.

The primary cells market research report is one of a series of new reports from The Business Research Company that provides primary cells market statistics, including primary cells industry global market size, regional shares, competitors with a primary cells market share, detailed primary cells market segments, market trends and opportunities, and any further data you may need to thrive in the primary cells industry. This primary cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The primary cells market size has grown rapidly in recent years. It will grow from $1.33 billion in 2023 to $1.49 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The expansion witnessed in the historical period can be ascribed to several factors, including the growing prevalence of cancer, heightened investments in regenerative medicine research, increasing demand for monoclonal antibodies, the benefits offered by primary human cells compared to cell lines, and the rising incidence of chronic diseases. These factors collectively contributed to the growth and advancement of primary cell-based research and applications during this period.

The primary cells market size is expected to see rapid growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.

In the forecast period, growth is anticipated due to several factors, including the increasing demand for personalized medicine, a heightened focus on stem cell research, rising investments in the field, and the growing adoption of cell-based assays. Major trends expected in this period include an increased demand for human primary cells, advancements in research tools and technologies, and a greater adoption of cell-based therapies. These trends collectively indicate a promising outlook for the expansion and development of primary cell-related research and applications in the coming years.

The anticipated increase in government funding for cancer research is poised to drive the growth of the primary cells market in the foreseeable future. Government funding plays a crucial role in supporting various aspects of primary cell research, including project funding, personnel support, infrastructure development, training, regulatory compliance, and technological advancements. For example, in May 2022, the American Institute for Cancer Research (AICR) in the United States sought $49 billion in funding for 2023, marking a $4.1 billion increase from the previous year's allocation of $46.4 billion. This surge in funding underscores the significant role of government support in fostering advancements in cancer research, consequently fueling the growth of the primary cells market.

Leading companies in the primary cell market are directing their efforts towards enhancing cell products, particularly novel serum-free mediums, to address the challenges encountered by cell therapy developers during the manufacturing workflow, especially in allogeneic cell therapy workflows. Novel serum-free mediums, devoid of animal-derived sera such as fetal bovine serum (FBS), are critical for cell culture or tissue culture. For instance, in January 2021, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced the Gibco CTS OpTmizer Pro Serum-Free Medium (SFM), specifically tailored for the growth and expansion of human T lymphocytes utilized in allogeneic cell therapies. This medium is engineered to enhance central memory phenotype and cell growth, resulting in increased production of central memory cells within shorter durations. Moreover, it supports extended workflows, facilitates high-density cultures, and is compatible with closed systems and automation, catering to the evolving needs of cell therapy developers.

In April 2023, AnaBios Corporation, a US-based biotechnology company, completed the acquisition of Cell Systems, further expanding its diverse portfolio of human tissue and cells. This strategic acquisition aimed to enrich AnaBios' translational tools and reagents, catering to academic, pharmaceutical, and biotech researchers. By leveraging Cell Systems' expertise in providing human primary cells and cell culture media, AnaBios seeks to optimize research programs and provide enhanced human insights to advance scientific discovery and therapeutic development efforts.

Major companies operating in the primary cells market report are Thermo Fisher Scientific Inc, Merck KGaA, BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection, Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc

North America was the largest region in the primary cells market in 2023. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary cells market consists of revenues earned by entities by providing services such as cell isolation services, primary cell culture services, cell characterization, and authentication. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary cell market also includes sales of cell culture media and reagents, cell culture plates and flasks, cell isolation kits, and transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Cells Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hematopoietic cells; Dermatophytes; Gastrointestinal Cells; Hepatocytes; Lung Cells; Renal Cells; Heart Cells; Musculoskeletal Cells; Other Primary Cells
• 2) By Origin: Human Primary Cells; Animal Primary Cells
• 3) By End User: Pharmaceuticals; Biotechnology Companies; Contract Research Organizations (CRO); Academic And Research Institutes; Other End Users
• Companies Mentioned: Thermo Fisher Scientific Inc; Merck KGaA; BD Biosciences; Corning Incorporated; Cytiva
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Primary Cells Market Characteristics

3. Primary Cells Market Trends And Strategies

4. Primary Cells Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Primary Cells Market Size and Growth

• 5.1. Global Primary Cells Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Primary Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Primary Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Primary Cells Market Segmentation

• 6.1. Global Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hematopoietic cells
• Dermatocytes
• Gastrointestinal Cells
• Hepatocytes
• Lung Cells
• Renal Cells
• Heart Cells
• Musculoskeletal Cells
• Other Primary Cells
• 6.2. Global Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Human Primary Cells
• Animal Primary Cells
• 6.3. Global Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceuticals
• Biotechnology Companies
• Contract Research Organizations (CRO)
• Academic And Research Institutes
• Other End Users

7. Primary Cells Market Regional And Country Analysis

• 7.1. Global Primary Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Primary Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Primary Cells Market

• 8.1. Asia-Pacific Primary Cells Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Primary Cells Market

• 9.1. China Primary Cells Market Overview
• 9.2. China Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Primary Cells Market

• 10.1. India Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Primary Cells Market

• 11.1. Japan Primary Cells Market Overview
• 11.2. Japan Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Primary Cells Market

• 12.1. Australia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Primary Cells Market

• 13.1. Indonesia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Primary Cells Market

• 14.1. South Korea Primary Cells Market Overview
• 14.2. South Korea Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Primary Cells Market

• 15.1. Western Europe Primary Cells Market Overview
• 15.2. Western Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Primary Cells Market

• 16.1. UK Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Primary Cells Market

• 17.1. Germany Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Primary Cells Market

• 18.1. France Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Primary Cells Market

• 19.1. Italy Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Primary Cells Market

• 20.1. Spain Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Primary Cells Market

• 21.1. Eastern Europe Primary Cells Market Overview
• 21.2. Eastern Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Primary Cells Market

• 22.1. Russia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Primary Cells Market

• 23.1. North America Primary Cells Market Overview
• 23.2. North America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Primary Cells Market

• 24.1. USA Primary Cells Market Overview
• 24.2. USA Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Primary Cells Market

• 25.1. Canada Primary Cells Market Overview
• 25.2. Canada Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Primary Cells Market

• 26.1. South America Primary Cells Market Overview
• 26.2. South America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Primary Cells Market

• 27.1. Brazil Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Primary Cells Market

• 28.1. Middle East Primary Cells Market Overview
• 28.2. Middle East Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Primary Cells Market

• 29.1. Africa Primary Cells Market Overview
• 29.2. Africa Primary Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Primary Cells Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Primary Cells Market Competitive Landscape And Company Profiles

• 30.1. Primary Cells Market Competitive Landscape
• 30.2. Primary Cells Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck KGaA
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. BD Biosciences
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Corning Incorporated
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Cytiva
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Primary Cells Market Other Major And Innovative Companies

• 31.1. Lonza Group Ltd
• 31.2. Charles River Laboratories Inc.
• 31.3. STEMCELL Technologies Inc
• 31.4. American Type Culture Collection
• 31.5. Cell Signaling Technology
• 31.6. BioIVT
• 31.7. InvivoGen
• 31.8. HemaCare Corporation
• 31.9. Creative Bioarray Inc.
• 31.10. PromoCell GmbH
• 31.11. CellGenix
• 31.12. AllCells LLC
• 31.13. Axol Bioscience Ltd
• 31.14. PBS Biotech Inc
• 31.15. AnaBios Corporation

32. Global Primary Cells Market Competitive Benchmarking

33. Global Primary Cells Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Primary Cells Market

35. Primary Cells Market Future Outlook and Potential Analysis

• 35.1 Primary Cells Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Primary Cells Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Primary Cells Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer